The serum and intestinal IL-17 secretion were enhanced in mice with TNBS-induced intestinal fibrosis and TL1A has been found to have an unexplored mechanism of inflammatory driven fibrosis, which may be connected with local activation of downstream IL-17A expression in IBD patients. The gene discussed is IL17A; the disease is inflammatory bowel disease.